A Deeper Dive Into Advanced and Future Directions in Treating Patients With Acute Myeloid Leukemia
Presented by Sandra E. Kurtin,(1) PhDc, ANP-C, AOCN®, and Gabrielle Zecha,(2) PA-C
1)The University of Arizona Cancer Center, Tucson, Arizona; 2)University of Washington, Seattle, Washington
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2018;9(3):336–344 |
© 2018 Harborside™
Acute myeloid leukemia is a disease that affects predominantly older patients, with a median age at diagnosis of 68. Overall prognosis is poor, but novel therapies that have emerged in recent years offer hope that outcomes can improve. In this comprehensive presentation, speakers covered a broad array of topics, including diagnostic workup, risk stratification, and novel therapeutic agents, and walked listeners through three illustrative case presentations.
For access to the full length article, please sign in